Home » Topics » Regulatory

Regulatory
RSS

Japanese authorities extend indication of Venogloblulin

Sep. 27, 2011

Asahi Kasei Pharma clear to market osteoporosis therapy in Japan

Sep. 27, 2011

Remicade approved in U.S. for new indication

Sep. 26, 2011

Avastin approved for new indication in Japan

Sep. 26, 2011

European approval of Removab broadened

Sep. 21, 2011

FDA approves Prolia for new indications

Sep. 20, 2011

Ono Pharmaceutical secures new Japanese approval for Glactiv

Sep. 19, 2011

Vibativ approved in Europe

Sep. 15, 2011

Ono Pharmaceutical set to launch Corebeta in Japan

Sep. 14, 2011

Novartis gains E.U. approval for Votubia

Sep. 8, 2011